Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?
作者信息
Matsuda Satoru, Mayanagi Shuhei, Irino Tomoyuki, Kawakubo Hirofumi, Kitagawa Yuko
机构信息
Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
出版信息
J Thorac Dis. 2019 Dec;11(12):5682-5684. doi: 10.21037/jtd.2019.12.59.
Abstract
摘要
相似文献
1
Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?T4期食管癌同步整合加量放疗的确定性放化疗——它会成为一种标准治疗方法吗？
J Thorac Dis. 2019 Dec;11(12):5682-5684. doi: 10.21037/jtd.2019.12.59.
2
A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer.一项采用同期加量放疗技术、选择性淋巴结照射和同期化疗治疗不可切除食管癌的 I/II 期放疗剂量递增试验。
Radiat Oncol. 2019 Mar 15;14(1):48. doi: 10.1186/s13014-019-1249-5.
3
Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial.局部晚期食管癌同步加量调强放疗的局部控制和毒性：前瞻性 I/II 期试验的中期结果。
J Thorac Oncol. 2017 Feb;12(2):375-382. doi: 10.1016/j.jtho.2016.10.013. Epub 2016 Oct 26.
4
Advances in radiotherapy for esophageal cancer.食管癌放射治疗的进展
Ann Transl Med. 2018 Feb;6(4):79. doi: 10.21037/atm.2017.11.28.
5
Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.比较同步调制加速放疗与同步整合加量调强放疗治疗局部晚期头颈癌的随机对照研究。
J Egypt Natl Canc Inst. 2018 Sep;30(3):107-115. doi: 10.1016/j.jnci.2018.06.001. Epub 2018 Jun 28.
6
A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer.局部晚期直肠癌术前调强放疗与图像引导放疗联合或不联合同步整合加量的剂量学分析
Technol Cancer Res Treat. 2015 Oct;14(5):557-63. doi: 10.7785/tcrt.2012.500442. Epub 2014 Nov 26.
7
Chemoradiotherapy and surgery for T4 esophageal cancer in Japan.日本T4期食管癌的放化疗与手术治疗
Surg Today. 2015 Nov;45(11):1360-5. doi: 10.1007/s00595-015-1116-4. Epub 2015 Jan 13.
8
Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.调强超分割放疗同步化疗序贯标准放化疗治疗胸内/颈段食管鳞癌的Ⅰ期临床试验。
Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):340-348. doi: 10.1016/j.ijrobp.2019.10.026. Epub 2019 Oct 23.
9
Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patients.局部晚期非小细胞肺癌患者调强放疗同步推量的疗效和毒性。
Clin Transl Oncol. 2017 Dec;19(12):1469-1477. doi: 10.1007/s12094-017-1689-z. Epub 2017 Jun 6.
10
Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study.同步调强加速放疗联合化疗用于食管癌的放射剂量递增：一项II期研究
Oncotarget. 2016 Apr 19;7(16):22711-9. doi: 10.18632/oncotarget.8050.
引用本文的文献
1
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.一项回顾性研究比较了 T4 期食管鳞癌患者在新辅助放化疗降期后行根治性放化疗与放化疗后手术的疗效。
Radiat Oncol. 2022 Aug 23;17(1):148. doi: 10.1186/s13014-022-02116-0.
本文引用的文献
1
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.不可切除局部晚期食管癌同期放化疗和放疗剂量同步整合增敏的 1/2 期临床试验结果。
JAMA Oncol. 2019 Nov 1;5(11):1597-1604. doi: 10.1001/jamaoncol.2019.2809.
2
Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE).三模式联合治疗诱导多西紫杉醇加顺铂和氟尿嘧啶与局部晚期不可切除的胸段食管鳞状细胞癌的标准放化疗的 III 期研究（JCOG1510：TRIANgLE）
Jpn J Clin Oncol. 2019 Dec 18;49(11):1055-1060. doi: 10.1093/jjco/hyz112.
3
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗（FLOT4）：一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
4
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review.临床T4期食管癌的治疗与临床结局：一项系统评价
Ann Gastroenterol Surg. 2018 Dec 13;3(2):169-180. doi: 10.1002/ags3.12222. eCollection 2019 Mar.
5
Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.质子束治疗与光子放射治疗局部晚期食管鳞状细胞癌的剂量学比较。
Radiat Oncol. 2018 Feb 9;13(1):23. doi: 10.1186/s13014-018-0966-5.
6
Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.质子束治疗与调强放疗治疗食管癌的根治性放化疗后对比结果：一项回顾性单机构分析。
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):667-676. doi: 10.1016/j.ijrobp.2017.06.2450. Epub 2017 Jun 27.
7
Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.食管癌放疗剂量递增的再探讨：2004 年至 2012 年国家癌症数据库的当代分析。
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):985-993. doi: 10.1016/j.ijrobp.2016.08.016. Epub 2016 Aug 23.
8
Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.多西他赛联合顺铂和5-氟尿嘧啶诱导化疗进行化学选择以及随后对局部晚期不可切除食管癌进行转化手术的II期研究
Br J Cancer. 2016 Nov 22;115(11):1328-1334. doi: 10.1038/bjc.2016.350. Epub 2016 Nov 3.
9
Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.日本可切除的Ⅱ/Ⅲ期食管鳞状细胞癌多学科治疗的当前进展
Ann Thorac Cardiovasc Surg. 2016 Oct 20;22(5):275-283. doi: 10.5761/atcs.ra.16-00111. Epub 2016 Jul 6.
10
Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis.未手术的局限性食管鳞癌患者接受同期放化疗时，较高的放射剂量是否会带来更好的结局？一项基于人群的倾向评分匹配分析。
Radiother Oncol. 2016 Jul;120(1):136-9. doi: 10.1016/j.radonc.2016.04.042. Epub 2016 May 17.
Zotero 插件